Enter your login e-mail to the account
Search
Search parameters
Search results
- New imaging methods in the diagnosis of prostate cancer
doc. MUDr. Jozef Marenčák, PhD.
(6/2023, Interdisciplinary consilium ) - Testicular cancer – comprehensive overview
prof. MUDr. Dalibor Ondruš, DrSc., Ústav experimentálnej onkológie SAV, Bratislava
(2/2010, Review articles ) - New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium ) - Tlačové správy
(4/2010, Information & comments ) - How early diagnose urological malignancy in the office of a general practitioner
doc. MUDr. Jozef Marenčák, PhD.
(5/2014, Review articles )
- Chronic subdural haematoma associated with advanced malignant tumor
prof. MUDr. Markéta Hermanová, Ph.D., MUDr. Dušan Hrabovský, doc. MUDr. Radim Jančálek, Ph.D., MUDr. Petr Burkoň, Ph.D., doc. MUDr. Jan Chrastina, Ph.D.
(2/2016, Case reports )
- Immunotherapy in the treatment of urological malignancies
MUDr. Jana Katolická, Ph.D., MUDr. Petr Filipenský, Ph.D.
(3/2019, Review articles ) - ACTUAL MEDICATION OF THE BONE METASTASE
MUDr. Ivan Kolombo, FEBU, MUDr. Martina Poršová, MUDr. Jaroslav Porš, MUDr. Richard Pabišta
(5-6/2007, Review articles ) - New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Is age the limitation of metastatic treatment prostate cancer?
MUDr. Jana Katolická, Ph.D.
(5/2018, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - HORMONAL REGULATIONS AND POSSIBILITIES OF INTERVENTION IN PROSTATE CANCER TREATMENT
MUDr. Kamil Belej, FEBU, , MUDr. Ondřej Kaplan
(1/2008, Review articles ) - Progression of prostate cancer after radical prostatectomy despite undetectable PSA levels
MUDr. Alexandra Jarošová, MUDr. Vladimír Študent, Ph.D., ml.
(2/2021, Communication from practice ) - Current treatment management of non-metastatic castration-resistant prostate cancer
MUDr. Nikol Rušarová, MUDr. Hana Študentová, Ph.D.
(1/2020, Review articles ) - Treatment of non-metastatic castration-resistant prostate cancer
MUDr. Ivo Kocák, Ph.D.
(4/2020, Review articles ) - CHEMOTHERAPY OF HORMONALLY REFRACTORY PROSTATIC CARCINOMA
doc. MUDr. Jozef Mardiak, CSc.
(2/2007, Review articles ) - The role of ARTAs in treating metastatic castration-resistant prostate cancer
MUDr. PharmDr. Jan Dvořák
(2/2019, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles )
- Overview of treatment of castration-resistant prostate cancer
MUDr. Jana Obertová
(4/2012, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Chemotherapy of hormonally refractory prostatic carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(1/2007, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Proper selection of patients for Radium 223 and its role in metastatic castration-resistant prostate cancer treatment
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(2/2021, Review articles ) - 18F-choline PET/CT in evaluation of therapeutic response of castration-resistant prostate cancer
Doc. MUDr. Soňa Balogová, PhD., MUDr. Lucia Noskovičová, MUDr. Lucia Kaliská FEBMN , MUDr. Marika Vereb, FEBMN, MUDr. Marek Bartovic
(3/2015, Review articles ) - Treatment of bone metastases in castration resistant prostate cancer – current view
doc. MUDr. Jozef Marenčák, PhD.
(3/2015, Review articles ) - Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Primary treatment of metastatic prostate cancer
MUDr. Matej Hrnčár, MUDr. Marek Lafférs, MUDr. Jozef Breznický, MUDr. Ján Šulgan, MUDr. Juraj Sokol, PhD., PhD., MUDr. Juraj Chudej, PhD.
(5/2017, Review articles ) - Lutetium-177-PSMA in therapy of metastatic prostate cancer
MUDr. Eva Takácsová, PhD.
(4/2022, Main topic ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Current treatment options for metastatic hormone-sensitive prostate cancer
MUDr. Jana Obertová, PhD.
(4/2023, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Metastatic prostate cancer: principles of hormonal treatment
Doc. MUDr. Frederico Goncalves, PhD.
(4/2014, Main topic ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - RADIOTHERAPY PROSTATE CANCER
MUDr. Pavol Dubinský, PhD.
(5/2008, Review articles ) - RADIOTHERAPY OF PROSTATIC CANCER
MUDr. Vladimír Malec, PhD.
(4/2006, Review articles ) - Position of radiotherapy in the treatment of generalized prostate cancer
MUDr. Viktor Rosenberg, PhD.
(3/2017, Review articles ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Extragonadálne germinatívne nádory
MUDr. Michal Chovanec, PhD.
(3/2018, Main topic ) - Treatment of patient with metastatic castrate refractory prostate cancer after androgen deprivation therapy failure
MUDr. Jozef Babeľa, PhD.
(S1/2019, Case reports ) - Death following brain metastases evolvement in patient with metastatic castration resistant adenocarcinoma of prostate treated by enzalutamide with low level PSA
MUDr. Roman Tomaškin, PhD.
(S1/2019, Case reports ) - Treatment of metastatic castrate-resistant prostate cancer with enzalutamide
MUDr. Klaudia Gočárová, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Enzalutamide in the treatment of metastatic castration-resistant prostate cancer
MUDr. Andrej Rosík, MUDr. Ladislav Slobodník
(S1/2019, Case reports ) - Molecular pathology of prostate carcinoma (part 2)
MUDr. Katarína Macháleková, doc. MUDr. Karol Kajo, PhD., Mgr. Petra Tilandyová, RNDr. Zora Lasabová, PhD., MUDr. Roman Tomaškin
(4/2009, Review articles ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - The role of epigenetic regulation in epithelial-to-mesenchymal transition
Mgr. Lucia Svoreňová, Mgr. Božena Smolková, PhD.
(6/2017, Review articles ) - TESTICULAR CANCER – DIAGNOSTICS AND TREATMENT
prof. MUDr. Dalibor Ondruš, DrSc., RNDr. Martina Ondrušová, PhD.
(3/2008, Review articles ) - Enzalutamide in treatment of the metastatic castration resistant prostate cancer
Doc. MUDr. Jozef Marenčák, PhD.
(6/2017, Drugs & drug classes ) - Stereotactic ultrahypofractionated radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(2/2023, Review articles ) - THE ROLE OF RADIOTHERAPY IN PAIN MANAGMENT IN ONCOLOGY
MUDr. Pavol Lukačko, MUDr. Alica Lacková
(5/2007, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Efficacy of darolutamide in the treatment castration sensitive prostate cancer
MUDr. Peter Leško, PhD.
(4/2024, Drugs & drug classes ) - Skeletal metastases
MUDr. Beata Špániková, PhD., MUDr. Lucia Vanovčanová, PhD., MUDr. Martin Kaško, PhD., prof. MUDr. Stanislav Špánik, CSc., MHA
(5/2023, Review articles ) - Therapy of castration-resistant prostate cancer from the point of view of nuclear medicine
MUDr. Eva Takácsová, PhD., Mgr. Žaneta Kantová
(1/2024, Review articles ) - Metastatic prostate cancer - new therapeutical approaches
MUDr. Patrik Palacka, PhD., MPH, MBA, Mgr. Soňa Herudová
(2/2015, Review articles ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Radiotherapy of pelvic lymph node in high risk prostate cancer and local treatment in metastatic disease
doc. MUDr. Pavol Dubinský, PhD., MHA
(4/2020, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Chemotherapy of hormone refractory prostate cancer
MUDr. Marta Škultétyová, MUDr. Andrea Mocná
(5/2009, Review articles ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Abiraterone in treatment of metastatic castrate resistant prostate cancer
prof. MUDr. Ján Kliment, CSc.
(2/2014, Drugs & drug classes ) - Management of sequential and combined treatment of a patient with metastatic prostate cancer
Doc. MUDr. Ján Breza, PhD.
(S1/2020, Case reports ) - Treatment of enzalutamide in the therapy of metastatic castration-resistant prostate cancer in postchemoindication
MUDr. Alexandra Szabová
(S1/2020, Case reports ) - Treatment of patient with metastatic prostate cancer – from sensitive to castration resistant disease – case report
MUDr. Vladimír Lenko, PhD., FEBU
(S1/2020, Case reports ) - Management of PSA progression after topical treatment of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(S1/2020, Case reports ) - Stereotactic body radiotherapy
doc. MUDr. Pavol Dubinský, PhD., MUDr. Martin Jasenčák
(2/2016, Main topic ) - Role of hormonal treatment in non-metastatic prostate cancer
MUDr. Ivan Dekánek
(6/2018, Review articles ) - CONTEMPORARY POSSIBILITY OF THE TREATMENT OF BONE METASTASES
prof. MUDr. Ľudovít Jurga, CSc.
(3/2007, Review articles - treatment ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles ) - PROSTATE CANCER – PRINCIPLE OF HORMONE THERAPY
prof. MUDr. Michal Horňák, DrSc.
(3/2006, Review articles ) - Androgen deprivation therapy and radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD.
(5/2018, Review articles )
- The use of biologic therapy in the prevention of pain and complications of osseal metastases in cancer diseases
MUDr. Kristina Križanová
(2/2013, Original articles )